Helps facilities outpace the competition with two new angiography product lines and Release 3.0 of ACUSON SC2000 for pediatric echocardiography

At the 62nd Annual Scientific Session & Expo of the American College of Cardiology (ACC), March 9-11 in San Francisco, Siemens Healthcare (Booth #S1909, Moscone South, Moscone Center) will offer solutions for sustainable cardiovascular care to help healthcare professionals move their cardiovascular care forward, enabling improved patient outcomes and enhanced economic efficiency. Offering a comprehensive portfolio of systems and support solutions that range from imaging modalities to information technology (IT) and in vitro diagnostics, Siemens is uniquely positioned to aid the cardiovascular community in making sound clinical decisions, providing safer procedures, improving operational efficiency, and maximizing its investments in healthcare technology and IT - ultimately helping to make the delivery of cardio-vascular care more sustainable.

"At ACC 2013, Siemens will reaffirm its status as a reliable innovator of cardiovascular systems and related tools," says Claus Grill, vice president, angiographic, cardiac and X-ray systems, Siemens Healthcare. "With our comprehensive cardiovascular portfolio, Siemens is uniquely positioned to enable providers to deliver the high-quality, cost-effective cardiovascular care that is necessary to remain competitive in the modern healthcare landscape." This offering of innovative health care solutions at competitive prices is a main goal of the Healthcare Sector's Agenda 2013 global initiative.
Advances in interventional cardiology
Siemens will display its revolutionary new Artis Q and Artis Q.zen angiography system family, which features X-ray tube and detector technology designed to improve minimally invasive therapy for coronary artery disease (CAD), structural heart disease (SHD), pediatrics, and electrophysiology.

The Artis Q.zen product line has been designed to combine the X-ray tube with a detector technology that allows imaging at ultra-low radiation levels. Artis Q.zen imaging can utilize doses as low as half the standard levels applied in angiography - an improvement resulting from several innovations, including a fundamental change in detector technology. The new crystalline silicon structure of the Artis Q.zen detector is designed to be more homogenous, allowing for more effective amplification of the signal, greatly reducing electronic noise even at ultra-low doses. The Artis Q.zen was developed to support better imaging quality at ultra-low-dose ranges, reducing radiation exposure for patients, physicians, and medical staff -which is particularly important in dose-sensitive application fields such as percutaneous coronary interventions, pediatric cardiology, and electrophysiology.

More HCB News